drugset / Trial / NCT00703482
A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to study the effect of different combinations of fenofibrate and coenzyme Q10 on ventricular diastolic function in patients with Type II diabetes
Timeline
- Start
- 2003-05
- Primary completion
- 2004-09
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CoQ10 | Other / unclassified | 100 mg | — |
| Subject | CoQ10 | Other / unclassified | 200 mg | — |
| Subject | Fenofibrate | Small molecule | 80 mg | — |
| Subject | Fenofibrate | Small molecule | 160 mg | — |
Indications
No indication recorded.